10 Nov 2020
FUNDAMENTAL RESEARCH AND INNOVATIONS FOR CARDIOVASCULAR MEDICINE 2020
INTERNATIONAL ONLINE CONFERENCE
Register online conference
Conference program
10 Nov 2020
10:00 – 10:45 (GMT+3)
10:00 – 10:45 (GMT+3)
Opening of the conference
WELCOMING WORDS:

  • Kaem Kirill Vladimirovich, SrVP of the Skolkovo Foundation, Russia
  • Paleev Filipp Nikolaevich, SrEVP of FSBI "National Medical Research Center of Cardiology" of the Ministry of Health, Russia
    10:15 – 11:30
    (GMT+3)
    10:15 – 11:30
    (GMT+3)
    Session I.
    Current fundamental research in cardiology
    Moderator:

    • Paleev Filipp Nikolaevich, Sr.EVP of FSBI "National Medical Research Center of Cardiology" of the Ministry of Health, Russia

    Speakers:

    • Kapelko Valerii Ignatevich, head of experimental heart pathology laboratory RCRPC Ministy of Health, Moscow, Russia. Natural Nitric Oxide promoting agent with prolonged action as a therapeutic agent for hypertension and heart failure
    • Semitko Sergei Petrovich, Director of Center for Interventional Cardiac Angiology, Sechenov University, Moscow, Russia Innovative aspects in the treatment of acute coronary syndrome
    • Piotr Bushman, Vice-president, American Heart of Poland, Poland. Bioresorbable vascular scaffold. Is it over or just a beginning of next generation technologies?
    • Veselova Oksana Mikhailovna, Senior researcher, Heart Metabolism Laboratory, Institute of Experimental Cardiology, Moscow, Russia. Cardioprotective properties of methylin peptide in experimental cardiac pathology
    11:30 – 12:45
    (GMT+3)
    11:30 – 12:45
    (GMT+3)
    Session II.
    Patenting, acceleration programs, legal optimization of start-up ownership and registration of medical devices. What medical inventors need to know?
    Moderator:

    • ZHelninova Tatiana Anatolevna, Innovative endovascular technologies, Skolkovo Foundation, Russia

    Speakers:

    • Pustovalova Mariia Leonidovna, Intellectual property centre, of the Skolkovo Foundation, Russia. Intellectual property protection in the field of biomedical innovations.
      Fundamentals of patent protection for medical devices
    • Melekhova Varvara Sergeevna, Acceleration director, Skolkovo Biomed, Moscow, Russia. Acceleration programs for biomedical startups. Actual opportunities in Russia
    • Paleev Filipp Nikolaevich, Sr.EVP of FSBI "National Medical Research Center of Cardiology" of the Ministry of Health, Russia. Small innovative enterprise is the optimal organizational form of partnership between inventors and government agencies
    • Gabai Polina Georgievna, "Fakultet Meditsinskogo Prava", Moscow, Russia. Legal aspects of the introduction of new medical technologies and registration of medical devices. Legal risks of startups
    12:45 – 14:00
    (GMT+3)
    12:45 – 14:00
    (GMT+3)
    Round table «Prospects for the development of biomedical innovations in Russia»
    Moderator:

    • Viller Aleksandr Grigorevich, Founder of Innovative Endovascular Technologies, Skolkovo Foundation, Russia

    Participants:

    • Krestinskii IUrii Aleksandrovich, CEO of the health care industry, SBERBANK, Russia
    • Fomin Viktor Viktorovich, Vice-rector for Clinical Affairs and Continuing Education, Sechenov University, Moscow, Russia
    • Kaem Kirill Vladimirovich, SrVP of the Skolkovo Foundation, Russia
    • Kudriashov Andrei Nikolaevich, CEO "Angiolain", Novosibirsk, Russia
    • Fainshtein Mikhail Leonidovich, CEO "Mircod", Moscow, Russia
    • Kurapeev Dmitrii Ilich, DDG FSBI "NMITS. V. A. Almazova", St. Petersburg, Russia
    • Polushkina Natalia Ruslanovna, Director, Skolkovo Biomed, Moscow, Russia.
    • Babunashvili Avtandil Mikhailovich, Center of Endosurgery and Lithotripsy, Moscow, Russia
    14:00 – 16:00
    (GMT+3)
    14:00 – 16:00
    (GMT+3)
    Session III.
    From idea to clinical trials.
    The milestones before the introduction of medical devices into clinical practice.
    Модераторы:

    • Paleev Filipp Nikolaevich (Moscow, Russia)
    • Viller Aleksandr Grigorevich (Moscow, Russia)

    Speakers:

    • James Muller, Harvard Medical School, Boston, USA. From Concept to FDA Approved Device to Detect Vulnerable Coronary Plaques - A 20-year, $200 million Start-up Journey in the United States
    • James Muller, Harvard Medical School, Boston, USA. Non-stenotic Vulnerable Coronary Plaques Can Now be Detected - Should they be Stented?
    • Volkov Oleg Igorevich, Medical Director "Angiolain", Novosibirsk, Russia. Strategic aspects of bringing innovative medical devices to the market
    • Tim Looney, Northeast Biomedical, Tyngsborough, USA. Product development services for cardiovascular medicine
    • SHatrov Aleksei Nikolaevich, Director "Nanomed", Penza, Russia. Occluder for congenital heart. Development process and results
    16:00 – 17:30
    (GMT+3)
    16:00 – 17:30
    (GMT+3)
    Session IV.
    Russian cardiovascular startups and R&D services of the Skolkovo Technopark
    Moderator:

    • Semitko Sergei Petrovich (Moscow, Russia)

    Speakers:


    • Viller Aleksandr Grigorevich, Moscow, Russia. Innovative bifurcated stenting systems
    • Glushchenko Leonid Vitalevich, Director "IK Sovremennye tekhnologii", Ulyanovsk, Russia. Resostent - bioresorbable expandable stent
    • Epifanov Artem Sergeevich, Director "ITM-Miokard" Skolkovo Foundation, Moscow, Russia. Reliable ECG pre-analysis system. Significance, scope, development prospects
    • Krivonosova Dina Vladimirovna, LLC "Akroway" Skolkovo Foundation, Moscow, Russia. Innovative medical complex for steam ablation of varicose veins of lower extremities
    • Kadyrov Dmitrii Eskenderovich, Skolkovo Technopark, Russia. R&D. services of the Skolkovo Technopark for biomedical projects
    17:30
    (GMT+3)
    17:30
    (GMT+3)
    Exchange of ideas and close of the conference
    Hosts of conference
    Association for the Promotion of Biomedical Innovations with the participation of the biomedical cluster of the Skolkovo Innovation Fund
    Foreign speakers
    James E. Muller, M.D.
    Boston, Massachusetts, USA
    James E. Muller, M.D. is an American cardiologist and medical device executive. He was a member of the faculty of Harvard Medical School for over 25 years, where he studied triggers of coronary artery plaque rupture and sudden cardiac death. He is believed to have coined the term "vulnerable plaque" to denote the plaques at high likelihood of rupture and causation of coronary thrombosis.

    He co-founded International Physicians for the Prevention of Nuclear War. This organization was awarded the Nobel Peace Prize in 1985, a prize properly attributed to the organization alone rather than any individual members, including co-founders.

    He is Founder, Chief Medical Officer, and Chairman of the Board of InfraReDx, Inc. which manufactures a catheter-based near-infrared spectroscopy system used to identify cholesterol rich plaques in patients undergoing cardiac catheterization. This system was cleared by the U.S. Food and Drug Administration for use to identify lipid core in coronary plaques of interest.

    https://www.youtube.com/watch?v=CRC8SvvvXJ4&t=34s

    The program of our conference includes two lectures by an outstanding cardiologist, which will contain not only the latest data on the diagnosis and treatment of "unstable plaque", but also aspects of innovative activities to promote unique ideas in clinical practice.
    Piotr P. Buszman, M.D.
    Katowice, Poland
    Piotr P. Buszman MD, experienced Interventional Cardiologists, Medical and Research Director in Center for Cardiovascular Research and Development American Heart of Poland with a demonstrated history of working in the hospital & health care industry. Skilled in Medical Devices, Cardiology, Healthcare, Medical Research, and Clinical Research. Strong research professional with a Master's degree from Medical University of Silesia. Professor and Cardiology Department Director in Andrzej Frycz Modrzewski Kraków University.

    Dr. Bushman's presentation will be devoted to the extremely topical issue of modern cardiovascular medicine - is there a future for bioresorbable coronary stents? Taking into account the involvement of the lecturer in preclinical testing of stents, the report will present the fundamental aspects of this problem.
    Tim Looney
    Tyngsboro, Massachusetts, USA
    Tim Looney has over 25 years of experience with technology projects including scope definition, design, development, schedule management, risk management, requirements gathering, and resource planning. Over his career, he has fulfilled a wide range of duties within engineering, product development, international operations, and quality management systems. Before founding Northeast Biomedical, Tim held several leadership roles at Creganna-Tactx Medical, CorNova, and Atrox Technologies.

    In addition to his role at Northeast Biomedical, he is a Senior Adjunct Faculty Member at the University of Massachusetts - Lowell, where he teaches courses in Medical Device Design, Computer-Aided Design and New Product Development.

    Tim received his B.S. in Mechanical Engineering from the University of Massachusetts – Lowell, his M.S. in Mechanical Engineering from Northeastern University, and his M.B.A. from Suffolk University.

    The experience of transforming the ideas set forth in patents into real prototypes of medical devices is one of the key links in the process of introducing innovative tools into clinical practice. Tim Looney's report will be of particular interest to inventors, participants in biomedical startups and representatives of innovative technology parks and investment funds.
    The main goal of the conference is the integration of practicing doctors, inventors, employees of institutions carrying out fundamental biomedical research in the field of cardiovascular medicine with representatives of investment funds, patent attorneys on the territory of the Skolkovo Innovation Fund.

    The scientific and practical conference will be attended by leading practicing clinicians, representatives of fundamental research institutions and laboratories, inventors, patent attorneys, representatives of start-ups and research departments of leading companies manufacturing products for the treatment of cardiovascular pathology, representatives of investment structures. The conference will focus on presenting fundamental developments and innovative projects to a wide range of specialists that will find application in the treatment of cardiovascular diseases.

    Participant level: from beginner to expert.

    Conference guide

    Executive secretary
    +7-926-2254147
    dr.alexviller@gmail.com


    Paleev Filipp Nikolaevich
    Viller Aleksandr Grigorevich
    Organising committee

    OFFICIAL ORGANIZER
    NOU DPO "Educational center Edikom":
    +7(499) 2571790, expo@edicom.ru



    SPONSORSHIP PACKAGES